company background image
PXS

Pharmaxis ASX:PXS Stock Report

Last Price

AU$0.061

Market Cap

AU$43.9m

7D

1.7%

1Y

-39.0%

Updated

01 Feb, 2023

Data

Company Financials +

PXS Stock Overview

Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide.

PXS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Pharmaxis Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pharmaxis
Historical stock prices
Current Share PriceAU$0.061
52 Week HighAU$0.11
52 Week LowAU$0.054
Beta0.47
1 Month Change0%
3 Month Change-7.58%
1 Year Change-39.00%
3 Year Change-46.96%
5 Year Change-77.82%
Change since IPO-86.44%

Recent News & Updates

Recent updates

We're Hopeful That Pharmaxis (ASX:PXS) Will Use Its Cash Wisely

Feb 28
We're Hopeful That Pharmaxis (ASX:PXS) Will Use Its Cash Wisely

Shareholders May Not Be So Generous With Pharmaxis Ltd's (ASX:PXS) CEO Compensation And Here's Why

Oct 27
Shareholders May Not Be So Generous With Pharmaxis Ltd's (ASX:PXS) CEO Compensation And Here's Why

Key Things To Understand About Pharmaxis' (ASX:PXS) CEO Pay Cheque

Mar 01
Key Things To Understand About Pharmaxis' (ASX:PXS) CEO Pay Cheque

We Think Pharmaxis (ASX:PXS) Can Afford To Drive Business Growth

Jan 04
We Think Pharmaxis (ASX:PXS) Can Afford To Drive Business Growth

Shareholder Returns

PXSAU PharmaceuticalsAU Market
7D1.7%-5.0%0.3%
1Y-39.0%-31.1%1.4%

Return vs Industry: PXS underperformed the Australian Pharmaceuticals industry which returned -30.2% over the past year.

Return vs Market: PXS underperformed the Australian Market which returned 2.4% over the past year.

Price Volatility

Is PXS's price volatile compared to industry and market?
PXS volatility
PXS Average Weekly Movement6.2%
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement8.5%
10% most volatile stocks in AU Market15.7%
10% least volatile stocks in AU Market3.4%

Stable Share Price: PXS is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: PXS's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199865Gary Phillipshttps://www.pharmaxis.com.au

Pharmaxis Ltd engages in the research, development, and commercialization of healthcare products for the treatment of fibrotic and inflammatory diseases worldwide. The company operates through two segments, Mannitol Respiratory Business and New Drug Development. It offers Bronchitol, an inhaled dry powder for the treatment of cystic fibrosis; and Aridol, an airways inflammation test that is used to identify twitchy or hyper-responsive airways, as well as to assist in diagnosing and managing asthma.

Pharmaxis Ltd Fundamentals Summary

How do Pharmaxis's earnings and revenue compare to its market cap?
PXS fundamental statistics
Market CapAU$43.86m
Earnings (TTM)AU$2.04m
Revenue (TTM)AU$17.93m

21.5x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PXS income statement (TTM)
RevenueAU$17.93m
Cost of RevenueAU$8.86m
Gross ProfitAU$9.07m
Other ExpensesAU$7.04m
EarningsAU$2.04m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Apr 28, 2023

Earnings per share (EPS)0.0028
Gross Margin50.59%
Net Profit Margin11.36%
Debt/Equity Ratio0%

How did PXS perform over the long term?

See historical performance and comparison